Litigation Details for EX PARTE APPLICATION OF SANDOZ CANADA INC. (D.N.J. 2020)
✉ Email this page to a colleague
EX PARTE APPLICATION OF SANDOZ CANADA INC. (D.N.J. 2020)
| Docket | ⤷ Try a Trial | Date Filed | 2020-03-04 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-10-13 |
| Cause | 28:1782 Letter rogatory - appointment | Assigned To | Michael Andre Shipp |
| Jury Demand | None | Referred To | Douglas Arpert |
| Patents | 7,767,225; 7,988,994; 8,383,150; 8,753,679 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in EX PARTE APPLICATION OF SANDOZ CANADA INC.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for EX PARTE APPLICATION OF SANDOZ CANADA INC. (D.N.J. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-03-04 | 1 | Exhibit 6 | . 7,767,225, 7,988,994, 8,383,150, 8,753,679, Publication No. US 2014/242159, European Patent No. EP …’013 Patents, or corresponding foreign patents and applications, including United States Patent Nos. …. 2. The term “’380 Patent” refers to Canadian Patent No. 2,620,380, entitled “Capsule …” 3. The term “’013 Patent” refers to Canadian Patent No. 2,762,013, entitled “Granulation…clinical studies described in the ’380 and ’013 Patents. | External link to document |
| 2020-09-22 | 3 | Opinion AND Memorandum | . US 7,767,225, US 7,988,994, US 8,383,150, US 8,753,679 and Application Publication No. US 2014/242159…. I-I.) The Patents in Issue are 2,620,380 (°°380 Patent’) and 2,762,013 ("013 Patent”). (/d.) “Each… ‘013 Patents, or corresponding foreign patents and applications, including United States Patent Nos. …collectively, “Roche”) and Sandoz are engaged in several patent litigations in the Federal Court of Canada. (Pet…“Each of the Patents in Issue name three inventors: Ronald Vladyka, Ramachandran Radhakrishnan, and Kenneth | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
